We thus transplanted CTL or MFN2-depleted PDX AML cells to primary recipient mice, and sorted and transplanted an equal amount of human AML cells from mice bone marrow of these two experimental conditions to secondary recipient mice after one week (Fig. 2E). This evidence concerns the gene MFN2 and acute myeloid leukemia.